TD Cowen cuts HubSpot stock price target on pricing changes

TD Cowen cut HubSpot’s price target to $250 from $270 while keeping a Hold rating, citing softer Q2 guidance and near-term disruption from pricing and packaging changes, including 50% AI price cuts and longer sales cycles. The company still posted a roughly 2% constant-currency revenue beat and raised full-year constant-currency guidance, but the raise captured only about two-thirds of the beat. The stock remains well below its 52-week high, and the analyst action reflects caution despite solid core growth and strong 84% gross margins.

Analysis

The market is treating HUBS like a quality compounder that has transitioned into a prove-it story: the issue is not demand collapse, but a change-management tax that can persist for multiple quarters. The key second-order effect is that pricing/packaging experimentation tends to depress conversion and elongate close times before it lifts ARPU; that means reported growth can stay noisy even if underlying cohort health remains intact. In other words, the stock is being priced on execution risk, not business quality, and that usually creates mean reversion only after the new pricing architecture stabilizes.

The more important read-through is competitive: if HubSpot is pushing outcome-based pricing with discounts on AI, it is effectively signaling that monetization of AI features remains elastic and under-optimized. That creates room for adjacent CRM and marketing automation vendors to compete on simplicity and transparency for the next 2-3 quarters, especially in SMB and mid-market where buyers are already sensitive to sales friction. If the market sees even modest billings deceleration or another guidance reset, multiple compression can continue because investors will extrapolate the pricing transition into a durability problem.

Contrarian view: the selloff may be overdone if the market is discounting a permanent growth impairment from what is likely a temporary packaging reset. A company with strong margins and net cash can absorb a few quarters of friction, and if AI pricing is reworked successfully, there is upside leverage to ARPU and attach rates later in the year. The inflection to watch is not top-line outperformance, but stabilization in cycle times and evidence that the new pricing model stops cannibalizing near-term conversion; that is the catalyst that can force short-covering over a 1-2 quarter horizon.

Key Decisions for Investors

• Stay tactically underweight HUBS for the next 1-2 quarters; the setup favors further multiple compression if billings or guidance disappoint again, with downside skew larger than near-term upside.
• Consider a pairs trade: long a more execution-stable software compounder and short HUBS into the next earnings cycle; the goal is to isolate idiosyncratic pricing-transition risk rather than macro software beta.
• For investors wanting convexity, buy short-dated call spreads only after evidence of sales-cycle stabilization; entry before that point is paying for a catalyst that has not yet arrived.
• If HUBS holds current levels through the next print and management shows no further guide-down, cover shorts aggressively; the stock can re-rate quickly once the market believes the transition tax is peaking.
• Use $250 as a tactical reference, not a valuation anchor: if the market starts rewarding the new pricing model before revenue inflects, the stock can move sharply on operating metric stabilization rather than headline growth.